학술논문

Phase I Study of LY2606368, a Checkpoint Kinase 1 Inhibitor, in Patients With Advanced Cancer.
Document Type
journal article
Source
Journal of Clinical Oncology; 5/20/2016, Vol. 34 Issue 15, p1764-1771, 8p
Subject
Language
ISSN
0732183X